Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F3038
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 25.1M 22.1M 20.38M 19.06M 35.72M 2.37B 36.38M 245M 94.88M 1.17B 94.24M 92.19M 4.06B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 27.98M 24.63M 22.72M 21.25M 39.81M 2.64B 40.55M 273M 106M 1.3B 105M 103M 4.53B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +13.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +13.33% | -.--% | - | - | 25.1M | ||
| +4.87% | +6.61% | +21.72% | -6.11% | 183B | ||
| -0.33% | -0.09% | -23.18% | +22.79% | 142B | ||
| +5.53% | +6.25% | -4.36% | -20.70% | 134B | ||
| -2.50% | -1.09% | -57.30% | -17.62% | 66.08B | ||
| +3.12% | +3.44% | +18.21% | -0.75% | 51.63B | ||
| -1.45% | -2.53% | -28.55% | -33.60% | 43.38B | ||
| +3.92% | +5.87% | +11.89% | +10.22% | 37.18B | ||
| +3.35% | +3.41% | +6.45% | +42.08% | 36.25B | ||
| +1.82% | +6.10% | -9.86% | -18.72% | 29.51B | ||
| Average | +3.17% | -0.26% | -7.22% | -2.49% | 80.33B | |
| Weighted average by Cap. | +2.54% | -0.60% | -4.99% | -2.70% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.16K 5.68K 5.32K 9.96K 660K 10.15K 68.31K 26.46K 325K 26.28K 25.71K 1.13M | 767K 675K 623K 583K 1.09M 72.3M 1.11M 7.49M 2.9M 35.66M 2.88M 2.82M 124M |
| Net income | -2.42M -2.13M -1.96M -1.84M -3.44M -228M -3.5M -23.59M -9.14M -112M -9.07M -8.88M -391M | -3.2M -2.81M -2.6M -2.43M -4.55M -301M -4.63M -31.19M -12.08M -149M -12M -11.74M -517M |
| Net Debt | 1.77M 1.56M 1.44M 1.35M 2.52M 167M 2.57M 17.28M 6.69M 82.35M 6.65M 6.51M 286M | 2.88M 2.53M 2.34M 2.18M 4.09M 271M 4.17M 28.07M 10.87M 134M 10.8M 10.56M 465M |
Employees
-
















